Abstract
ObjectiveTo estimate prevalence of HIV infection in Nigeria and to examine variations by geopolitical zones and study characteristics to inform policy, practice and research.MethodsWe conducted a comprehensive search of bibliographic databases including PubMed, CINAHL, PsycINFO, Global Health, Academic Search Elite and Allied and Complementary Medicine Database (AMED) and grey sources for studies published between 1 January 2008 and 31 December 2019. Studies reporting prevalence estimates of HIV among pregnant women in Nigeria using a diagnostic test were included. Primary outcome was proportion (%) of pregnant women living with HIV infection. A review protocol was developed and registered (PROSPERO 2019 CRD42019107037).ResultsTwenty-three studies involving 72 728 pregnant women were included. Ten studies were of high quality and the remaining were of moderate quality. Twenty-one studies used two or more diagnostic tests to identify women living with HIV. Overall pooled prevalence of HIV among pregnant women was 7.22% (95% CI 5.64 to 9.21). Studies showed high degree of heterogeneity (I2=97.2%) and evidence of publication bias (p=0.728). Pooled prevalence for most individual geopolitical zones showed substantial variations compared with overall prevalence. North-Central (6.84%, 95% CI 4.73 to 9.79) and South-West zones (6.27%, 95% CI 4.75 to 8.24) had lower prevalence whereas South-East zone (17.04%, 95% CI 9.01 to 29.86) had higher prevalence.ConclusionsWhile robust national prevalence studies are sparse in Nigeria, our findings suggest 7 in every 100 pregnant women are likely to have HIV infection. These figures are consistent with reported prevalence rates in sub-Saharan African region. WHO has indicated much higher prevalence in Nigeria compared with our findings. This discrepancy could potentially be attributed to varied methodological approaches and regional focus of studies included in our review. The magnitude of the issue highlights the need for targeted efforts from local, national and international stakeholders for prevention, diagnosis, management and treatment.
Reference62 articles.
1. HIV in pregnancy - an update;Chilaka;Eur J Obstet Gynecol Reprod Biol,2021
2. amfAR-The Foundation for AIDS Research . Statistics: women and HIV/AIDS. 2021. Available: https://www.amfar.org/about-hiv-and-aids/facts-and-stats/statistics--women-and-hiv-aids/ [Accessed 23 Oct 2021].
3. United Nations Programme on HIV/AIDS (UNAIDS) . Forty years into the HIV epidemic, AIDS remains the leading cause of death of women of reproductive age—UNAIDS calls for bold action. 2020. Available: https://www.unaids.org/sites/default/files/20200305_PR_weve-got-the-power_en.pdf [Accessed 10 Nov 2021].
4. Pregnancy and HIV disease progression in an early infection cohort from five African countries;Wall;Epidemiology,2017
5. He S , Shuang G , Yinglan W , et al . Prevalence and factors associated with hepatitis C among pregnant women in China: a cross-sectional study. Sci Rep 2023;13:759. doi:10.1038/s41598-023-27668-3
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献